Tag Archives: research and development

Collaboration seeks to speed new TB treatments

By on .

About half a century has passed since a new tuberculosis drug was put to use, and in that time the challenges to successful treatment of the disease have only grown, with bacteria adapting faster to conditions that allowed it to flourish than science and funding for research. Morphing into forms that require from months to […]

The PDP+ Fund: Accelerating R&D in New Products for Diseases of Poverty

By on .

This guest blog about innovative financing for global health was written by Holly Wong, vice president for public policy at the International AIDS Vaccine Initiative; Dr. Mary Moran, director of health policy at The George Institute for International Health; and Dr. Paul Herrling, head of the Novartis Institutes for Developing World Medical Research. In addition to […]

Public and Private Sector Partners Help to Jump Start Development of New TB Drug Combinations

By on .

This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB Drug Development, the Bill & Melinda Gates Foundation, the Treatment Action Campaign, and representatives from the pharmaceutical industry to announce a new collaboration to accelerate […]

New MDR-TB Study Highlights the Promise of R&D in Fight Against Deadly Bug

By on .

In a small new study, researchers found that linezolid, an antibiotic first approved in 2000, may be an effective component in the treatment of multidrug-resistant drug-resistant tuberculosis. But as previous research of this drug has suggested, linezolid is far from a perfect cure for the global epidemic of drug-resistant TB, and the findings reinforce the […]

Two New TB Reports from TAG

By on .

The Treatment Action Group has released two new reports on tuberculosis, both valuable resources in the effort to combat this global TB epidemic. The first report details the level of global funding for TB research and development; a total of $510 million was invested by 71 organizations, public and private, in TB R&D in 2008, […]